Sera Prognostics Q1 2026 Earnings InLine Loss and No Revenue as Stock Surges on Pipeline Progress YALA Q1 2026 Earnings EPS of 016 Reported Stock Rises Amid Limited Disclosures Summit Therapeutics SMMT Q1 2026 Earnings WiderThanExpected Loss Stalls Momentum Dianthus Therapeutics Q1 2026 Earnings BetterthanExpected Loss Despite No Revenue RB Global Q1 2026 Earnings Slight EPS Beat Highlights Resilient Operations SO Q1 2026 Earnings Earnings Per Share Beat Estimates Amid Steady Utility Performance